SCHEMBL353235

SCHEMBL353235

CNC(=O)C1CCOC(C)(C)C1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.54
ALOX15 P16050 1/20 0.54
ALDH1A1 P00352 5/20 0.46
GLA P06280 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CHRNB2 P17787 2/20 0.35
CHRNA4 P43681 2/20 0.35
CHRNA7 P36544 1/20 0.35
CHRNB4 P30926 1/20 0.34
CHRNA3 P32297 1/20 0.34
GAA P10253 2/20 0.34
HTT P42858 2/20 0.34
TP53 P04637 1/20 0.34
PKM P14618 1/20 0.34
KDM4E B2RXH2 2/20 0.33
MAPT P10636 2/20 0.33
LMNA P02545 1/20 0.33
APOBEC3G Q9HC16 1/20 0.33
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14276813 0.84 POLB (0.56) POLBALOX15ALDH1A1GLASMN1; SMN2
SCHEMBL322744 0.79 POLB (0.54) POLBALOX15ALDH1A1GLASMN1; SMN2
SCHEMBL31085334 0.78 POLB (0.54) POLBALOX15ALDH1A1GLASMN1; SMN2
SCHEMBL19119509 0.77 POLB (0.53) POLBALOX15ALDH1A1GLASMN1; SMN2
SCHEMBL4730994 0.77 POLB (0.53) POLBALOX15ALDH1A1GLASMN1; SMN2
SCHEMBL3434689 0.76 POLB (0.49) POLBALOX15ALDH1A1GLASMN1; SMN2
SCHEMBL15125182 0.74 POLB (0.50) POLBALOX15ALDH1A1GLASMN1; SMN2
SCHEMBL15114094 0.74 POLB (0.50) POLBALOX15ALDH1A1GLASMN1; SMN2
SCHEMBL19132863 0.73 POLB (0.43) POLBALOX15ALDH1A1GAAHTT
SCHEMBL19132868 0.73 POLB (0.43) POLBALOX15ALDH1A1GLASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148380-B2 Antibacterial amide and sulfonamide substituted heterocyclic urea compounds CRESTONE, INC. (US) 2012-04-03 US disclosed
US-20120015941-A1 Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds CRESTONE, INC. (US) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015941-A1 Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds NAAA, AADAC, RPSA POLB 1884/4885ALOX15 4600/4885ALDH1A1 2806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.